Back to MORGAN STANLEY MORGAN STANLEY

PDSBPDSB
Showing 8 of 9 quarters

Position history for MORGAN STANLEYMORGAN STANLEY's holdings in PDS BIOTECHNOLOGY CORP

MORGAN STANLEY holds 313,922 shares of PDSB (PDS BIOTECHNOLOGY CORP), worth $276,597 as of 2026-Q2. The position was increased (+7904.1% shares).

Current Value

$276,597

Current Shares

313,922

Total Value Change

+$171,806

Total Shares Change

+286,490

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
313,922
+7904.1%
$276,5970.0%$0.88
26
2026-Q1
Decreased
3,922
-20.3%
$2,3730.0%$0.67
0
2025-Q4
Decreased
4,922
-40.4%
$3,7890.0%$0.80
0
2025-Q3
Increased
8,259
+11.1%
$8,3410.0%$1.01
13
2025-Q2
Decreased
7,434
-57.1%
$9,8870.0%$1.41
0
2025-Q1
Decreased
17,315
-3.2%
$20,6050.0%$1.26
0
2024-Q4
Decreased
17,894
-34.8%
$29,1670.0%$1.69
0
2024-Q3
Decreased
27,432
-62.9%
$104,7910.0%$3.37
0

Other major holders of PDSB: BlackRock Finance, Inc., TWO SIGMA ADVISERS, LP, TWO SIGMA INVESTMENTS, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used